| Derar Zakaryya Shanwan Albashaireh, MBBS | |
|
3670 Parker Blvd Ste 101, Pueblo, CO 81008-2285 | |
| (719) 562-2900 | |
| (719) 924-1592 |
| Full Name | Derar Zakaryya Shanwan Albashaireh |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 15 Years |
| Location | 3670 Parker Blvd Ste 101, Pueblo, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083902431 | NPI | - | NPPES |
| 9000163537 | Medicaid | CO |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkview Medical Center, Inc | Pueblo, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Parkview Ancillary Services Corporation | 4385722511 | 267 |
News Archive
Dow reported earnings of $0.84 per share. This compares with reported earnings of $0.50 per share in the same period last year.
Although the pharmaceutical industry has dedicated enormous research efforts over the last 50 years to identify new targets and develop new active ingredients, these efforts have met with limited success.
Preeclampsia is the most dangerous form of hypertension during a pregnancy and can be fatal for both mother and child. Though it is known to originate in the placenta, the root causes remain largely a mystery.
Most cancer drugs are designed to target dividing cells, but a new study by Stony Brook University researchers suggests that targeting invasive cells may be a new strategy to treat metastatic cancer.
In the scramble to bring successful apps for the diagnosis of skin cancer to market there is a concern that a lack of testing is risking public safety, according to research led by the University of Birmingham.
› Verified 3 days ago
| Entity Name | Parkview Ancillary Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982878765 PECOS PAC ID: 4385722511 Enrollment ID: O20080429000248 |
News Archive
Dow reported earnings of $0.84 per share. This compares with reported earnings of $0.50 per share in the same period last year.
Although the pharmaceutical industry has dedicated enormous research efforts over the last 50 years to identify new targets and develop new active ingredients, these efforts have met with limited success.
Preeclampsia is the most dangerous form of hypertension during a pregnancy and can be fatal for both mother and child. Though it is known to originate in the placenta, the root causes remain largely a mystery.
Most cancer drugs are designed to target dividing cells, but a new study by Stony Brook University researchers suggests that targeting invasive cells may be a new strategy to treat metastatic cancer.
In the scramble to bring successful apps for the diagnosis of skin cancer to market there is a concern that a lack of testing is risking public safety, according to research led by the University of Birmingham.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Derar Zakaryya Shanwan Albashaireh, MBBS Po Box 560825, Denver, CO 80256-0825 Ph: (719) 595-7580 | Derar Zakaryya Shanwan Albashaireh, MBBS 3670 Parker Blvd Ste 101, Pueblo, CO 81008-2285 Ph: (719) 562-2900 |
News Archive
Dow reported earnings of $0.84 per share. This compares with reported earnings of $0.50 per share in the same period last year.
Although the pharmaceutical industry has dedicated enormous research efforts over the last 50 years to identify new targets and develop new active ingredients, these efforts have met with limited success.
Preeclampsia is the most dangerous form of hypertension during a pregnancy and can be fatal for both mother and child. Though it is known to originate in the placenta, the root causes remain largely a mystery.
Most cancer drugs are designed to target dividing cells, but a new study by Stony Brook University researchers suggests that targeting invasive cells may be a new strategy to treat metastatic cancer.
In the scramble to bring successful apps for the diagnosis of skin cancer to market there is a concern that a lack of testing is risking public safety, according to research led by the University of Birmingham.
› Verified 3 days ago
Dr. Christopher John Calcagno, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 N. Grand Ave., Ste. 300, Pueblo, CO 81003 Phone: 719-562-2001 Fax: 719-562-2742 | |
Christopher Jon Stark, Internal Medicine Medicare: Medicare Enrolled Practice Location: 400 W 16th St, Pueblo, CO 81003 Phone: 719-595-2218 Fax: 719-595-7994 | |
Greg Alan Bowman, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 N Grand Ave, Suite 500, Pueblo, CO 81003 Phone: 719-545-0663 Fax: 719-595-7903 | |
Lauren E. Sullenberger, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 902 Lakeview Ave, Pueblo, CO 81004 Phone: 719-557-5855 Fax: 719-557-5097 | |
Peter Lochow, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3670 Parker Blvd Ste 101, Pueblo, CO 81008 Phone: 719-564-1544 Fax: 719-924-1593 | |
Dr. Raj Vashistha, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3670 Parker Blvd., Ste 101, Pueblo, CO 81008 Phone: 719-564-1544 Fax: 719-924-1592 | |
Dr. Rebecca Elizabeth Holder, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1207 Pueblo Boulevard Way, Pueblo, CO 81005 Phone: 719-542-0032 Fax: 719-553-1904 |